United States · Bill · S
S. 4013 (116th)
Pandemic Anti-Monopoly Act
Introduced
18 June 2020
Last action
—
Status
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Sponsors
—
Subjects
Discovery layer
Source updated
14 January 2025
Summary
Pandemic Anti-Monopoly Act This bill places a moratorium on certain mergers and acquisitions during the COVID-19 (i.e., coronavirus disease 2019) pandemic. Specifically, the bill prohibits certain transactions such as acquisitions (1) by firms with over $100 million in revenue; (2) by financial institutions or equity funds with over $100 million in capitalization; and (3) involving firms with exclusive patents pertaining to COVID-19 pandemic-related production, manufacturing, distribution, or infrastructure. However, a waiver may be granted if the participating firms demonstrate that the transaction will advance critical national security, economic, or public health interests during the emergency. Further, the bill establishes a legal presumption against a transaction that may pose a risk to the government's ability to respond to the national emergency declared due to COVID-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 18 June 2020
Introduced in Senate (PDF)
Introduced in Senate · EN · 18 June 2020
Introduced in Senate
summary · EN · 18 June 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/4013
- Open data entity: https://api.congress.gov/v3/bill/116/s/4013